1. Home
  2. PFAI vs SCYX Comparison

PFAI vs SCYX Comparison

Compare PFAI & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFAI
  • SCYX
  • Stock Information
  • Founded
  • PFAI 2015
  • SCYX 1999
  • Country
  • PFAI Canada
  • SCYX United States
  • Employees
  • PFAI N/A
  • SCYX N/A
  • Industry
  • PFAI Farming/Seeds/Milling
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFAI Consumer Staples
  • SCYX Health Care
  • Exchange
  • PFAI Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • PFAI 31.4M
  • SCYX 28.5M
  • IPO Year
  • PFAI 2025
  • SCYX 2014
  • Fundamental
  • Price
  • PFAI $1.64
  • SCYX $0.73
  • Analyst Decision
  • PFAI
  • SCYX
  • Analyst Count
  • PFAI 0
  • SCYX 0
  • Target Price
  • PFAI N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • PFAI 203.4K
  • SCYX 114.5K
  • Earning Date
  • PFAI 01-01-0001
  • SCYX 08-07-2025
  • Dividend Yield
  • PFAI N/A
  • SCYX N/A
  • EPS Growth
  • PFAI N/A
  • SCYX N/A
  • EPS
  • PFAI 0.07
  • SCYX N/A
  • Revenue
  • PFAI $2,715,477.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • PFAI N/A
  • SCYX $463.61
  • Revenue Next Year
  • PFAI N/A
  • SCYX $310.80
  • P/E Ratio
  • PFAI $22.31
  • SCYX N/A
  • Revenue Growth
  • PFAI 1084.72
  • SCYX N/A
  • 52 Week Low
  • PFAI $1.57
  • SCYX $0.66
  • 52 Week High
  • PFAI $4.40
  • SCYX $2.29
  • Technical
  • Relative Strength Index (RSI)
  • PFAI N/A
  • SCYX 41.87
  • Support Level
  • PFAI N/A
  • SCYX $0.66
  • Resistance Level
  • PFAI N/A
  • SCYX $0.78
  • Average True Range (ATR)
  • PFAI 0.00
  • SCYX 0.05
  • MACD
  • PFAI 0.00
  • SCYX -0.00
  • Stochastic Oscillator
  • PFAI 0.00
  • SCYX 37.37

About PFAI Pinnacle Food Group Limited Class A Common Shares

Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups and are developing a hydroponic growing system for urban farms.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: